approval
saveELELYSO (TALIGLUCERASE ALFA) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: POWDER. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalDec 22, 2025 · 283d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalJan 17, 2025 · 622d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalMay 9, 2023 · 1241d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalAug 30, 2022 · 1493d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalNov 3, 2020 · 2158d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalOct 21, 2019 · 2537d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalDec 20, 2016 · 3572d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalJun 15, 2016 · 3760d ago
same company · ±60 days · 6
- approvalmedroxyprogesterone acetate: DEPO-SUBQ PROVERA 104 (MEDROXYPROGESTERONE ACETATE) — FDA approvalJul 11, 2024
- approvalmedroxyprogesterone acetate: DEPO-PROVERA (MEDROXYPROGESTERONE ACETATE) — FDA approvalJul 11, 2024
- approvalclindamycin hydrochloride: CLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalJul 29, 2024
- approvalMEDROL: MEDROL (METHYLPREDNISOLONE) — FDA approvalJun 5, 2024
- approvalMETHYLPREDNISOLONE ACETATE: DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approvalJun 5, 2024
- approvaltofacitinib citrate ER: XELJANZ XR (TOFACITINIB CITRATE) — FDA approvalMay 14, 2024
comments(0)
5-min edit window · permanent after that